
Rebecca Dent, MD, FRCP (Canada) - TROP2 and Triple-Negative Breast Cancer: The Rationale and Emerging Evidence for Exploring the Therapeutic Potential of TROP2-Targeted Antibody-Drug Conjugates in Earlier Lines and Disease-Stage Settings
From PeerVoice Oncology & Haematology Audio by PeerVoice
January 7, 2026 · 22 min
About this episode
Rebecca Dent discusses the rationale and emerging evidence for TROP2-targeted therapies in triple-negative breast cancer.
Rebecca Dent, MD, FRCP (Canada) - TROP2 and Triple-Negative Breast Cancer: The Rationale and Emerging Evidence for Exploring the Therapeutic Potential of TROP2-Targeted Antibody-Drug Conjugates in Earlier Lines and Disease-Stage Settings
People in this episode
Guest: Rebecca Dent, MD, FRCP
Topics covered
- TROP2
- Triple-Negative Breast Cancer
- Antibody-Drug Conjugates
- Therapeutic Potential
- Disease-Stage Settings
Keywords
- TROP2
- Triple-Negative Breast Cancer
- Antibody-Drug Conjugates
- Therapeutic Potential
- Cancer Treatment
Mentioned in this episode
Organizations: Canada
Products: TROP2-Targeted Antibody-Drug Conjugates
More episodes of PeerVoice Oncology & Haematology Audio
- Andrea Necchi, MD - Working With Our Patients as a Member of the MDT: A Bladder Cancer Awareness Month 2026 CME Initiative · June 9, 2026 · 21 min
- Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances Emerge · June 5, 2026 · 19 min
- Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer · June 5, 2026 · 20 min
- Marwan Fakih, MD - Making a Difference in Refractory Metastatic Colorectal Cancer: Practical Strategies to Positively Impact the Patient Journey Across Practice Settings · May 26, 2026 · 28 min
- Trisha Wise-Draper, MD, PhD - Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck Cancer · May 26, 2026 · 54 min
- Martin Köbel, MD - Scoring Folate Receptor-Alpha Expression in Gynecological Cancers: An Interactive Pathology Masterclass · May 18, 2026 · 30 min
Explore listener stats, chart rankings, contacts and more on the PeerVoice Oncology & Haematology Audio podcast page.